Schulich school of Medicine and Dentistry logo Family Medicine Schulich School of Medicine & Dentistry

May 2015 Research and Publications

Recent Publications – Journal Articles

Vingilis E, Erickson PG, Toplak ME, Kolla NJ, Mann RE, Seeley J,   vanderMaas M, Daigle DS.  Attention Deficit Hyperactivity Disorder Symptoms, Comorbidities, Substance Use, and Social Outcomes among Men and Women in a Canadian Sample.  BioMed Research International, Article ID 982072,
http://www.hindawi.com/journals/bmri/aa/982072/

Sorge GB, Flora DB, van der Maas M, Vingilis E, Erickson P, Kolla NJ, Mann RE, Seeley J, Toplak ME.  Using factor analytic models to examine the association between attention-deficit/hyperactivity disorder symptoms and health-related outcomes in a representative population survey. Atten Defic Hyperact Disord. 2015 Mar 26. http://www.ncbi.nlm.nih.gov/pubmed/25809202

Osmun WE, Kim GP, Harrison ER. Patients with multiple comorbidities: Simple teaching strategy. Can Fam Physician. 2015 Apr;61(4):378-9.
http://www.ncbi.nlm.nih.gov/pubmed/25873707

Osmun WE, Chan N, Solomon R. Approach to caring for developmentally disabled adults in the community: medical, ethical, and legal considerations. Can Fam Physician. 2015 Jan;61(1):27-31.
http://www.ncbi.nlm.nih.gov/pubmed/25609519

Hsia RY, Thind A, Zakariah A, Hicks ER, Mock C. Prehospital and Emergency Care: Updates from the Disease Control Priorities, Version 3. World J Surg. 2015 Apr 7. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25847225

MacNeil SD, Liu K, Shariff SZ, Thind A, Winquist E, Yoo J, Nichols A, Fung K, Hall S, Garg AX.  Secular trends in the survival of patients with laryngeal carcinoma, 1995-2007.  Curr Oncol. 2015 Apr;22(2):e85-99. doi: 10.3747/co.22.2361.
http://www.ncbi.nlm.nih.gov/pubmed/25908925

Ryan BL, Koval J, Corbett B, Stewart M, Campbell K, Thind A. Identifying potentially influential observations in weighted logistic regression. The Research Data Centres – Information and Technical Bulletin. Release Date March 24, 2015; Catalogue no. 12-002-X – No. 2015001. Statistics Canada.  http://www5.statcan.gc.ca/olc-cel/olc.action?objId=12-002-X&objType=2&lang=en&limit=0

Ritchie LM,  Schull MJ, Martiniuk AL, Barnsley J, Arenovich T, van Lettow M, Chan AK, Mills EJ, Makwakwa A, Zwarenstein M.  A knowledge translation intervention to improve tuberculosis care and outcomes in Malawi: a pragmatic cluster randomized controlled trial.  Implement Sci. 2015 Mar 28;10(1):38.
http://www.ncbi.nlm.nih.gov/pubmed/25890186

Migliore A, Bizzi E, Herrero-Beaumont J, Petrella RJ, Raman R, Chevalier X. The discrepancy between recommendations and clinical practice for viscosupplementation in osteoarthritis:  mind the gap! Eur Rev Med Pharmacol Sci . 2015 Apr:19(7);1124-9
http://www.ncbi.nlm.nih.gov/pubmed/25912569

Petrella RJ, Emans PJ, Alleyne J, Dellaert F, Gill DP, Maroney M. Safety and performance of Hydros and Hydros-TA for knee osteoarthritis: A prospective, multicenter, randomized, double-blind feasibility trial.  BMC Musoloskeletel  Disord 2015 March 18; 16:57:1-9. DOI 10.1186/s12891-015-0513-6
http://www.ncbi.nlm.nih.gov/pubmed/25887932

Petrella RJ, Gill DP, Berrou JP, on behalf of the POWER survey Study Group. Effect of Eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients with diabetes:  Results of the POWER Survey. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 2015 Mar 1: 8:173-180
http://www.ncbi.nlm.nih.gov/pubmed/25848310